thiazoles has been researched along with Squamous Cell Carcinoma of Head and Neck in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (75.00) | 24.3611 |
| 2020's | 4 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbash, Z; Bauman, JE; Cho, J; Grandis, JR; Jin, N; Johnson, DE; Jura, N; Kang, H; Keam, B; Kim, HR; Kim, MO; Krogan, NJ; Lee, MJ; Li, H; Mills, GB; Ng, PK; Swaney, DL; Tarcic, G; Torosyan, H; VanLandingham, NK; Zeng, Y | 1 |
| Bayley, A; Bratman, SV; Cho, J; Day, D; Giuliani, M; Hansen, AR; Hope, A; Jang, R; Karithanam, R; Kim, J; O'Sullivan, B; Prawira, A; Ringash, J; Siu, LL; Spreafico, A; Waldron, J; Weinreb, I | 1 |
| Furukawa, K; Naruse, T; Okuyama, K; Omori, K; Tsuchihashi, H; Umeda, M; Yanamoto, S | 1 |
| Ailles, L; Barrett, JW; Boutros, PC; Fung, K; Howlett, CJ; MacNeil, D; Meens, J; Mymryk, JS; Nichols, AC; Pinto, N; Plantinga, P; Ruicci, KM; Stecho, W; Yoo, J | 1 |
| Baer-Dubowska, W; Kleszcz, R; Krajka-Kuźniak, V; Paluszczak, J | 1 |
| Barrett, JW; Fung, K; Khan, MI; MacNeil, D; Mymryk, JS; Nichols, AC; Pinto, N; Ruicci, KM; Yoo, J | 1 |
| Badarni, M; Balaban, N; Cohen, L; Dinur, AB; Elkabets, M; Grénman, R; Joshua, BZ; Prasad, M; Rotblat, B; Yegodayev, KM; Zorea, J | 1 |
| Alvarado, D; Duvvuri, U; Godse, NR; Grandis, JR; Hedberg, ML; Kemp, C; Khan, NI; Kim, S; Kulkarni, S; LaVallee, T; Meister, KS | 1 |
| Chen, CC; Huang, LY; Huang, WC; Lin, YC; Lin, YT; Wei, TT; Wu, MH | 1 |
| Brockhoff, G; Doescher, J; Haug, A; Mißlbeck, M; Pickhard, A; Piontek, G; Reiter, R; Rudelius, M; Schiefler, C; Schuettler, D | 1 |
| Fukuda, S; Inamura, N; Kimura, T; Nishihara, H; Tanaka, S; Tanino, M; Tsuda, M; Wang, L; Yanagi, H | 1 |
| Dunn, EF; Iida, M; Li, C; Wheeler, DL | 1 |
| Chinn, SB; Hochstim, C; Masood, R; Schorn, VJ; Sinha, UK; Zhu, S | 1 |
| Knecht, R; Kurzweg, T; Laban, S; Möckelmann, N | 1 |
| Bednash, JS; Chiosea, SI; Grandis, JR; Morariu, EM; Otte, CG; Seethala, RR; Wheeler, SE | 1 |
| Ang, KK; Glisson, B; Johnson, FM; Milas, L; Molkentine, DP; Molkentine, JM; Raju, U; Riesterer, O; Wang, ZQ | 1 |
1 review(s) available for thiazoles and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year's literature.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzodioxoles; Carcinoma, Squamous Cell; Cetuximab; Combined Modality Therapy; Dasatinib; ErbB Receptors; Fluorouracil; Gefitinib; Head and Neck Neoplasms; Humans; Indoles; Neoplasm Recurrence, Local; Palliative Care; Pyrimidines; Pyrroles; Quinazolines; Quinazolinones; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Sunitinib; Thiazoles | 2012 |
1 trial(s) available for thiazoles and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck.
Topics: Aged; Chemoradiotherapy; Cisplatin; Female; Humans; Middle Aged; Squamous Cell Carcinoma of Head and Neck; Thiazoles | 2020 |
14 other study(ies) available for thiazoles and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.
Topics: Animals; Class I Phosphatidylinositol 3-Kinases; Head and Neck Neoplasms; Humans; Male; Mice; Middle Aged; Mutation; Protein Domains; Squamous Cell Carcinoma of Head and Neck; Thiazoles | 2021 |
Selective inhibition of PI3K110α as a novel therapeutic strategy for cetuximab‑resistant oral squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cetuximab; Chemoradiotherapy, Adjuvant; Class I Phosphatidylinositol 3-Kinases; Drug Resistance, Neoplasm; Female; Humans; Male; Mice; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Invasiveness; Progression-Free Survival; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Thiazoles; Xenograft Model Antitumor Assays | 2020 |
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma.
Topics: Animals; Apoptosis; Axl Receptor Tyrosine Kinase; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; MAP Kinase Signaling System; Mice; Prognosis; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Thiazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
The inhibition of c-MYC transcription factor modulates the expression of glycolytic and glutaminolytic enzymes in FaDu hypopharyngeal carcinoma cells.
Topics: Cell Line, Tumor; Cell Survival; Glutamine; Glycolysis; Humans; Hypopharyngeal Neoplasms; Proto-Oncogene Proteins c-myc; Squamous Cell Carcinoma of Head and Neck; Thiazoles | 2018 |
ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition.
Topics: Cell Cycle; Cell Line, Tumor; Drug Resistance, Neoplasm; Genes, ras; Head and Neck Neoplasms; Humans; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mechanistic Target of Rapamycin Complex 1; Molecular Targeted Therapy; Mutation, Missense; Neoplasm Proteins; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins p21(ras); Ribosomal Protein S6 Kinases; RNA Interference; Squamous Cell Carcinoma of Head and Neck; Thiazoles; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein | 2018 |
Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy.
Topics: Animals; Anthracenes; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Esophageal Neoplasms; Head and Neck Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Squamous Cell Carcinoma of Head and Neck; Thiazoles; Tongue; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Xenograft Model Antitumor Assays | 2019 |
HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinoma.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Mice; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptor, ErbB-3; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Thiazoles; Up-Regulation; Xenograft Model Antitumor Assays | 2019 |
Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Growth Processes; Cell Line, Tumor; Dasatinib; Drug Synergism; Endoplasmic Reticulum Stress; Female; Head and Neck Neoplasms; Humans; Metformin; Mice; Mice, Nude; Pyrimidines; Squamous Cell Carcinoma of Head and Neck; Thiazoles; Xenograft Model Antitumor Assays | 2014 |
Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR / SphK1 crosstalk.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cetuximab; Disease Progression; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paraffin Embedding; Phosphotransferases (Alcohol Group Acceptor); Receptor Cross-Talk; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Thiazoles | 2014 |
Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antigens, CD; Cadherins; Carcinogenesis; Carcinoma, Squamous Cell; Cell Enlargement; Cell Line, Tumor; Diamines; Epithelial-Mesenchymal Transition; Female; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Prognosis; Proto-Oncogene Proteins c-myc; Receptor, Notch1; Squamous Cell Carcinoma of Head and Neck; Thiazoles; Vimentin; Young Adult | 2017 |
Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Dasatinib; ErbB Receptors; Head and Neck Neoplasms; Humans; Neoplasms, Squamous Cell; Protein Kinase Inhibitors; Protein Transport; Pyrimidines; Squamous Cell Carcinoma of Head and Neck; Thiazoles | 2010 |
Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition.
Topics: Animals; Apoptosis; Blotting, Western; Carcinoma; Carcinoma, Squamous Cell; Disease Models, Animal; Enzyme Inhibitors; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Squamous Cell; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Radiation Tolerance; Squamous Cell Carcinoma of Head and Neck; Thiazoles; Treatment Outcome | 2011 |
Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; CSK Tyrosine-Protein Kinase; Dasatinib; Disease Progression; ErbB Receptors; Head and Neck Neoplasms; Humans; Immunoprecipitation; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-yes; Pyrimidines; Random Allocation; RNA Interference; RNA, Small Interfering; Squamous Cell Carcinoma of Head and Neck; src-Family Kinases; Thiazoles; Transplantation, Heterologous | 2012 |
Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways.
Topics: Active Transport, Cell Nucleus; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Nucleus; CSK Tyrosine-Protein Kinase; Dasatinib; DNA Repair; ErbB Receptors; Focal Adhesion Protein-Tyrosine Kinases; Head and Neck Neoplasms; Humans; Protein Kinase Inhibitors; Pyrimidines; Radiation Tolerance; Squamous Cell Carcinoma of Head and Neck; src-Family Kinases; Thiazoles | 2012 |